These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9718194)
1. The Escherichia coli chaperonin 60 (groEL) is a potent stimulator of osteoclast formation. Reddi K; Meghji S; Nair SP; Arnett TR; Miller AD; Preuss M; Wilson M; Henderson B; Hill P J Bone Miner Res; 1998 Aug; 13(8):1260-6. PubMed ID: 9718194 [TBL] [Abstract][Full Text] [Related]
2. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures. Kawaguchi H; Chikazu D; Nakamura K; Kumegawa M; Hakeda Y J Bone Miner Res; 2000 Mar; 15(3):466-73. PubMed ID: 10750561 [TBL] [Abstract][Full Text] [Related]
3. Enhancement by conditioned medium of stretched calvarial bone cells of the osteoclast-like cell formation induced by parathyroid hormone in mouse bone marrow cultures. Soma S; Matsumoto S; Takano-Yamamoto T Arch Oral Biol; 1997 Mar; 42(3):205-11. PubMed ID: 9188990 [TBL] [Abstract][Full Text] [Related]
4. Surface-associated protein from Staphylococcus aureus stimulates osteoclastogenesis: possible role in S. aureus-induced bone pathology. Meghji S; Crean SJ; Hill PA; Sheikh M; Nair SP; Heron K; Henderson B; Mawer EB; Harris M Br J Rheumatol; 1998 Oct; 37(10):1095-101. PubMed ID: 9825749 [TBL] [Abstract][Full Text] [Related]
5. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity. Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630 [TBL] [Abstract][Full Text] [Related]
6. The cellular actions of interleukin-11 on bone resorption in vitro. Hill PA; Tumber A; Papaioannou S; Meikle MC Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935 [TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro. Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132 [TBL] [Abstract][Full Text] [Related]
8. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures. Ikegame M; Rakopoulos M; Martin TJ; Moseley JM; Findlay DM J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876 [TBL] [Abstract][Full Text] [Related]
9. Decreased nitric oxide levels stimulate osteoclastogenesis and bone resorption both in vitro and in vivo on the chick chorioallantoic membrane in association with neoangiogenesis. Collin-Osdoby P; Rothe L; Bekker S; Anderson F; Osdoby P J Bone Miner Res; 2000 Mar; 15(3):474-88. PubMed ID: 10750562 [TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. Collin-Osdoby P; Rothe L; Bekker S; Anderson F; Huang Y; Osdoby P J Bone Miner Res; 2002 Oct; 17(10):1859-71. PubMed ID: 12369790 [TBL] [Abstract][Full Text] [Related]
11. Role of prostaglandin in the formation of osteoclasts induced by capsular-like polysaccharide antigen of Actinobacillus actinomycetemcomitans strain Y4. Ueda N; Nishihara T; Ishihara Y; Amano K; Kuroyanagi T; Noguchi T Oral Microbiol Immunol; 1995 Apr; 10(2):69-75. PubMed ID: 7675521 [TBL] [Abstract][Full Text] [Related]
12. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Hill PA; Reynolds JJ; Meikle MC Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521 [TBL] [Abstract][Full Text] [Related]
13. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts. Shu G; Yamamoto K; Nagashima M Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994 [TBL] [Abstract][Full Text] [Related]
14. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway. Akatsu T; Ono K; Katayama Y; Tamura T; Nishikawa M; Kugai N; Yamamoto M; Nagata N J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340 [TBL] [Abstract][Full Text] [Related]
15. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein. Weir EC; Lowik CW; Paliwal I; Insogna KL J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Lader CS; Flanagan AM Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689 [TBL] [Abstract][Full Text] [Related]
17. The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro. Kawashima M; Fujikawa Y; Itonaga I; Takita C; Tsumura H Mod Rheumatol; 2009; 19(2):192-8. PubMed ID: 19198759 [TBL] [Abstract][Full Text] [Related]
18. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139]. Fenton AJ; Martin TJ; Nicholson GC J Cell Physiol; 1993 Apr; 155(1):1-7. PubMed ID: 8468357 [TBL] [Abstract][Full Text] [Related]
19. Ketoconazole and phorbol myristate acetate regulate osteoclast precursor fusion in primary murine marrow culture. Fan X; Biskobing DM; Bain S; Rubin J J Bone Miner Res; 1996 Sep; 11(9):1274-80. PubMed ID: 8864902 [TBL] [Abstract][Full Text] [Related]
20. Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption. Choi SJ; Devlin RD; Menaa C; Chung H; Roodman GD; Reddy SV J Clin Invest; 1998 Oct; 102(7):1360-8. PubMed ID: 9769328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]